To The Moon

$NEBIUS(NBIS)$ will deploy approximately 80MW of new data center capacity in Israel. This project is in partnership with Mega Or DC, with a total investment of around $880–900 million. This deal means $NBIS will expand its operations in Israel roughly 10× within about a year — the future looks incredibly promising!

$Moderna, Inc.(MRNA)$ Sinovac has confirmed that MRNA technology is safe! So I went all in without hesitation. My position has already gained 30% returns. The reasons for its rapid rally amid the market recovery are severe undervaluation and heavy short selling pressure.

$ProShares Ultra Silver(AGQ)$ Did you guys catch these high-quality stocks in this big rally? They already brought me some solid gains in December — well played.

$Navitas Semiconductor Corp(NVTS)$ has been added to the Kyber rack power supply vendor list, and the company working most closely with Navitas is Xinerui Technology. Xinerui has also achieved mass production of GaN matrix power supplies based on Navitas’ gallium nitride devices.This GaN matrix converter is particularly well suited to NVIDIA $NVIDIA(NVDA)$ ’s next-generation Kyber architecture power requirements. As a single-stage converter, it delivers extremely fast response times.Load up, brothers.

$CRITICAL METALS CORPORATION(CRML)$ The U.S. first dealt with Venezuela and now is talking about taking over Greenland — all mainly for resources. Especially Greenland’s rare earths — that’s also why the U.S. rare earths stock Critical Metals (CRML) has been soaring. I bought it on Monday and checked today — made a killing.

$Spdr S&P Biotech Etf(XBI)$ The globally watched U.S. biotech “Spring Gala” — the JPMorgan Healthcare Conference — kicks off next Monday and will run for a full week. Big M&A moves among innovative pharma companies in this new cycle are often the first major highlights. Stay tuned!

$Novavax(NVAX)$ was a nice surprise in a choppy market. As biotech sentiment picked up and vaccines got some attention again, the bounce came fast. Caught the move, locked in a small profit, and moved on — no greed, just good timing and a satisfying trade.

$NEBIUS(NBIS)$ This run in NBIS was a happy one. Costs dropped by up to 26x, perfectly lining up with the AI wave reshaping the global economy. As the GPU vs CPU battle plays out again inside AI models, NBIS feels built for this moment. Clean logic, good timing — booked a small profit and felt great about it.

$Palantir Technologies Inc.(PLTR)$ Despite Palantir’s relatively high valuation, Truist Securities initiated coverage with a Buy rating and a $223 price target, citing the company’s massive opportunity in driving general AI adoption across government and enterprise clients. Palantir’s position as an analytics- and data-driven software leader gives it long-term upside. Just follow the trade and buy along.

$iShares Biotechnology ETF(IBB)$ The biotech sector, represented by IBB, has recently significantly outperformed small-cap indices like the Russell 2000, yet its valuation remains well below the 2021 peak, leaving plenty of room for further upside.

$Intel(INTC)$ On Wednesday, Intel (INTC.US) surged more than 10%, marking its biggest intraday gain since September 18 last year, and is now trading at $43.71. Intel CEO Lip-Bu Tan emphasized that the company has delivered on its promise to ship the first 18A process products in 2025. Senior Vice President Johnson added that 2026 will be a strategic turning point for both the industry and Intel, signaling a new phase of technology iteration and market reshaping. Still bullish going forward.

$RXO INC(RXO)$ was a steady hold this time. With markets choppy, money rotated back into logistics and supply-chain names that offer both defense and rebound potential.

$MP Materials Corp.(MP)$ is shaping up to be one of the biggest real winners of the “Greenland strategy.”Based on the latest updates as of January 2026, MP could get involved in Greenland-related DPA projects through its subsidiaries.It makes sense — if the U.S. government wants strategic minerals processed, MP is the obvious choice with an existing refining facility.With the stock already down nearly 50% from its highs, building a position around the 60 level feels relatively safe.

$Direxion Daily S&P Biotech Bull 3x Shares(LABU)$ was all about sentiment and timing this round. After biotech churned at the lows, money flowed back fast, and the leverage really kicked in. Caught the rebound, locked in a small profit, and moved on. In this kind of market, taking it and staying disciplined feels best.

$Beyond Meat, Inc.(BYND)$ Bill Gates just made another move, this time into artificial butter. A California startup called Savor claims it can recreate real butter using just water, air, and a few additives, with plans to hit supermarkets by 2027. Gates tried it himself, was impressed, and decided to invest. Clean tech, sustainability, and long-term potential — hard not to keep an eye on this one. Small move, big vision.

Hello everyone! Today i want to share some option strategies with you!1.Closed out this $Eos Energy Enterprises Inc.(EOSE)$ put-write trade for $3,600 profit! 🤑 Rolled the buying power into a new put-write trade targeting the 10P strike.Would like EOSE to hold above the 12 level, but am taking the profit and being protective of capital for now. That said, getting assigned at 10 is better than at 12.Image2.Took a small put-write trade on $Constellation(STZ)$ to play earnings. Targeted the recent bottom around 126.This trade paid for the driving range with the gents today. 🏌️🏽Will try to close out for 0.05 tomorrow, assuming AH price action holds into open.Image3. $APPL

Hello everyone! Today i want to share some technical analysis with you!1. $Tesla Motors(TSLA)$ Breakout buyers crushed.Now it’s a support test.Let’s see who gets paid. Image2. $Robinhood(HOOD)$ The October 10th massacre didn't just break crypto. Image3. $Apple(AAPL)$ You buying this retest? Image4. $Lockheed Martin(LMT)$ Who says Trump markets aren't fun? 🎢Image5. $Invesco QQQ(QQQ)$ Diamonds are forever 💎Image6. $Alphabet(GOOG)$ New Year, Same 💚 Since IPO, the stock has a 82% win rate in January with an avg return of +4.5%ImageFor SG user